University of Rochester Doctors Among Nation’s Best for Cancer Care

October 16, 2007

Several oncologists and surgeons at University of Rochester Medical Center’s James P. Wilmot Cancer Center and Golisano Children’s Hospital at Strong are included in America’s Top Doctors for Cancer, a valued guide for patients. They are the only Rochester area doctors included in the 650-page book.

“Clearly this demonstrates the level of skill and expertise available within the University of Rochester Medical Center’s oncology teams,” said Richard I. Fisher, M.D., director of the Wilmot Cancer Center and vice president for clinical services for the Medical Center, who was included in the book.

The guide, considered an authoritative resource for patients seeking the best cancer care, includes:

  • Richard I. Fisher, M.D., an internationally recognized expert in lymphoma care and research. Fisher has led numerous national and international studies in Hodgkin’s disease and non-Hodgkin’s lymphoma. Patients and physicians throughout the world seek his expertise on lymphoma.
  • Regis O’Keefe, M.D., Ph.D., chair of Orthopaedics and Rehabilitation, specializes in cancers of the bone, muscle and soft tissue around the skeleton.  He is director of the Center for Musculoskeletal Research, overseeing the research of 16 faculty and two dozen graduate students and post-doctoral fellows. O’Keefe’s NIH grant support has consistently placed him among the most highly funded orthopaedic surgeon-clinician scientists in the United States.
  • Louis “Sandy” Constine, M.D., professor and vice chair of Radiation Oncology, is internationally recognized for his expertise in acute and chronic effects of chemotherapy and radiation therapy on normal tissues. He specializes in lymphomas, sarcomas, brain tumors and pediatric malignancies.
  • David Korones, M.D., associate professor of Pediatrics and Hematology/Oncology, focuses on brain tumor care and research for children and adults. He leads research into new therapies for brain tumors and management of side effects.
  • Kristin Skinner, M.D., chief of Surgical Oncology and director of the Multidisciplinary Breast Cancer Program, is an outstanding breast surgeon.  She also leads clinical and translational research evaluating biologic markers of breast cancer risk, possible molecular diagnostic markers in breast cancer, the application of intraductal approaches to breast cancer diagnosis and treatments, and the potential for less invasive forms of treatment for ductal carcinoma in situ of the breast.
  • Thomas Watson, M.D., associate professor of Surgery and chief of Thoracic Surgery, is an expert in foregut (esophageal / stomach) and pulmonary surgery.  He has extensive experience in open and minimally invasive procedures, including laparoscopic and thoracoscopic approaches.

The Wilmot Cancer Center is the leader in cancer care and research in the Rochester and Finger Lakes region.  With a team of 80 doctors specializing in each form of cancer, and more than 300 nurses, staff and volunteers work together to provide outstanding care for people with cancer.

###

For Media Inquiries:
Leslie White
(585) 273-1119
Email Leslie White